Amplification of EDHF-type vasodilatations in TRPC1-deficient mice
Amplification of EDHF-type vasodilatations in TRPC1-deficient mice
复制标题
DOI:
10.1111/j.1476-5381.2010.00985.x
复制
发表时间:
2010-12-01
影响因子:
7.3
通讯作者:
Kohler, Ralf
中科院分区:
文献类型:
--
作者:
Schmidt, Kjestine;Dubrovska, Galyna;Kohler, Ralf
BACKGROUND AND PURPOSETRPC1 channels are expressed in the vasculature and are putative candidates for intracellular Ca2+ handling. However, little is known about their role in endothelium-dependent vasodilatations including endothelium-derived hyperpolarizing factor (EDHF) vasodilatations, which require activation of Ca2+-activated K+ channels (K-Ca). To provide molecular information on the role of TRPC1 for K-Ca function and the EDHF signalling complex, we examined endothelium-dependent and independent vasodilatations, K-Ca currents and smooth muscle contractility in TRPC1-deficient mice (TRPC1-/-).EXPERIMENTAL APPROACHVascular responses were studied using pressure/wire myography and intravital microscopy. We performed electrophysiological measurements, and confocal Ca2+ imaging for studying K-Ca channel functions and Ca2+ sparks.KEY RESULTSTRPC1 deficiency in carotid arteries produced a twofold augmentation of TRAM-34- and UCL1684-sensitive EDHF-type vasodilatations and of endothelial hyperpolarization to acetylcholine. NO-mediated vasodilatations were unchanged. TRPC1-/- exhibited enhanced EDHF-type vasodilatations in resistance-sized arterioles in vivo associated with reduced spontaneous tone. Endothelial IKCa/SKCa-type K-Ca currents, smooth muscle cell Ca2+ sparks and associated BKCa-mediated spontaneous transient outward currents were unchanged in TRPC1-/-. Smooth muscle contractility induced by receptor-operated Ca2+ influx or Ca2+ release and endothelium-independent vasodilatations were unaltered in TRPC1-/-. TRPC1-/- exhibited lower systolic blood pressure as determined by tail-cuff blood pressure measurements.CONCLUSIONS AND IMPLICATIONSOur data demonstrate that TRPC1 acts as a negative regulator of endothelial K-Ca channel-dependent EDHF-type vasodilatations and thereby contributes to blood pressure regulation. Thus, we propose a specific role of TRPC1 in the EDHF-K-Ca signalling complex and suggest that pharmacological inhibition of TRPC1, by enhancing EDHF vasodilatations, may be a novel strategy for lowering blood pressure.